Issue 4/2021

Sonic Hedgehog is a novel prognostic biomarker in patients with oral squamous cell carcinoma

 Piotr Cierpikowski, Anna Lis-Nawara, Julia Bar

DOI: 10.4149/neo_2021_201204N1304

Research status and the prospect of POSTN in various tumors (673 — 682)

Yue Yu, Chang-Ming Tan,  Yuan-Yuan Jia

DOI: 10.4149/neo_2021_210223N239

DNase1L3 suppresses hepatocellular carcinoma growth via inhibiting complement autocrine effect (683 — 691)

 Qing-Yun Chen, Lei Li, Da-Qin Suo

DOI: 10.4149/neo_2021_201010N1069

lncRNA RNCR2 facilitates cell proliferation and epithelial-mesenchymal transition in melanoma through HK2-mediated Warburg effect via targeting miR-495-3p (692 — 701)

Bao-Xue Duan, Xue-Rui Geng,  Yao-Qun Wu

DOI: 10.4149/neo_2021_201120N1255

SPOCK1 promotes the proliferation and migration of colon cancer cells by regulating the NF-κB pathway and inducing EMT (702 — 710)

Han-Xiong Liu, Yuan-Yuan Cao,  Jia-Yao Qu

DOI: 10.4149/neo_2021_201031N1158

LAMC1 is related to the poor prognosis of patients with gastric cancer and facilitates cancer cell malignancies (711 — 718)

 Zhi-Rong Han, Xiao-Lin Jiang, Wen-Chuan Fan

DOI: 10.4149/neo_2021_201117N1239

microRNA-204 shuttled by mesenchymal stem cell-derived exosomes inhibits the migration and invasion of non-small-cell lung cancer cells via the KLF7/AKT/HIF-1α axis (719 — 731)

Xiao-Ni Liu, Chui-Bin Zhang, Hai Lin, Xiao-Yuan Tang, Rong Zhou, Hui-Lan Wen,  Jie Li

DOI: 10.4149/neo_2021_201208N1328

A novel antitumor peptide inhibits proliferation and migration and promotes apoptosis in glioma cells by regulating the MKK6/p38 signaling pathway (732 — 741)

Rong Wang, Bo-Wen Li, Nai-Yuan Shao, Dan-Ni Deng,  Feng Zhi

DOI: 10.4149/neo_2021_201109N1196

Assessment of the expression and response of PD-1, LAG-3, and TIM-3 after neoadjuvant radiotherapy in rectal cancer (742 — 750)

Qing-Qin Peng, Jin-Luan Li, Pei-Ling Xin, Kai-Xin Du, Xiao-Yi Lin,  Jun-Xin Wu, Mu-Tian Zhang, Xiang-Quan Kong

DOI: 10.4149/neo_2021_201210N1341

TRIM44 facilitates ovarian cancer proliferation, migration, and invasion by inhibiting FRK (751 — 759)

Xiu-Zhang Yu, Jia-Ling Yuan, Hui Ye, Ke Yi, Ming-Rong Qie,  Min-Min Hou

DOI: 10.4149/neo_2021_201128N1285

CD150 and CD180 are negative regulators of IL-10 expression and secretion in chronic lymphocytic leukemia B cells (760 — 769)

 Valeriia Shcherbina, Inna Gordiienko, Larysa Shlapatska, Danilo Gluzman, Svitlana Sidorenko

DOI: 10.4149/neo_2021_210104N8

The role of angiotensin-(1-7) on acquired platinum resistance-induced angiogenesis in non-small cell lung cancer in vitro and in vivo (770 — 779)

Yan-Lai Geng, Yong-Jie Ding, Lei Ni, Kan-Di Xu, Van-Minh Le,  Ri Ji,  Yun Feng

DOI: 10.4149/neo_2021_201213N1347

Circ-sirt1 inhibits growth and invasion of gastric cancer by sponging miR-132-3p/miR-212-3p and upregulating sirt1 expression (780 — 787)

Qing-Ke Li, Yan-Kun Liu, Jing-Wu Li, Yuan-Ting Liu, Yu-Feng Li,  Bing-Hui Li

DOI: 10.4149/neo_2021_210218N222

LncRNA ANRIL promotes multiple myeloma progression and bortezomib resistance by EZH2-mediated epigenetically silencing of PTEN (788 — 797)

Li-Hui Yang, Peng Du, Wei Liu, Li-Kun An, Jian Li, Wen-Yi Zhu, Shuo Yuan, Lei Wang,  Lei Zang

DOI: 10.4149/neo_2021_210205N184

Depletion of circRNA circ_CDK14 inhibits osteosarcoma progression by regulating the miR-520a-3p/GAB1 axis (798 — 809)

Peng-Fei Wu, Xiao-Ming Tang, Hai-Lang Sun, Hai-Tao Jiang, Jian Ma,  Ying-Hui Kong

DOI: 10.4149/neo_2021_201206N1319

Knockdown of USP9X reverses cisplatin resistance by decreasing β-catenin expression in nasopharyngeal carcinoma cells (810 — 822)

Wen-Xuan Lu, Guo-Sheng Gan,  Bo Yang

DOI: 10.4149/neo_2021_201227N1410

Heterogeneity and prognosis of programmed cell death-ligand 1 expression in the circulating tumor cells of non-small cell lung cancer (823 — 831)

He-Lin Wang, Jie-Qing Wu, Ying Wang, Jian Yu, Xiao-Na Mao, Zhuo-Ran Li, Hong-Rui Niu, Cai-Ling Jin, Xiao-Jue Wang, Zhuo-Hong Yan, Ling Yi, Bin Yang, Pan-Jian Wei,  Hong-Tao Zhang,  Shu-Cai Zhang

DOI: 10.4149/neo_2021_210115N67

The combination of PRL-3 inhibitor with sorafenib synergistically promotes AML apoptosis (832 — 841)

Xiaomin Chen, Dade Rong, Wanhua Cai,  Xiuzhen Tong,  Haihe Wang

DOI: 10.4149/neo_2021_210301N265

The clinical and prognostic significance of LGR5 in GC: A meta-analysis of IHC assay and bioinformatics analysis (842 — 851)

Fei Guo, Tao Yang, Rende Guo,  Yu Wang

DOI: 10.4149/neo_2021_200714N726

Metabolomic profiling of blood plasma of patients with lung cancer and malignant tumors with metastasis in the lungs showed similar features and promising statistical discrimination against controls (852 — 860)

Miroslava Sarlinova,  Eva Baranovicova, Michaela Skalicanova, Anton Dzian, Martin Petras, Jan Lehotsky, Dagmar Kalenska, Peter Racay, Tatiana Matakova, Erika Halasova

DOI: 10.4149/neo_2021_210103N3

Efficacy and safety of regorafenib or fruquintinib plus camrelizumab in patients with microsatellite stable and/or proficient mismatch repair metastatic colorectal cancer: an observational pilot study (861 — 866)

Feng-E Jiang, Hui-Juan Zhang, Cai-Yan Yu,  Ai-Na Liu

DOI: 10.4149/neo_2021_201228N1415

18F-FDG PET/CT metabolic parameters and HER2 expression in colorectal cancer (875 — 881)

Ziyi Yang, Shuai Liu, Yuyun Sun, Junyan Xu, Jinjin Jiang, Xiaoxi Ma, Yingjian Zhang,  Shaoli Song

DOI: 10.4149/neo_2021_200803N807

Morbidity and mortality after open radical cystectomy and ileal diversion - 10 years experience and a comprehensive assessment in a single tertiary center (882 — 891)

 Joana Do Carmo Silva, Marek Babjuk, Štěpán Veselý, Pavel Dušek, Ladislav Jarolím,  Antonín Brisuda

DOI: 10.4149/neo_2021_210202N161

Survival of cancer patients in Fujian, Southeast China: a population-based cancer registry study (892 — 898)

Yan Zhou, Zhi-Sheng Xiang, Jing-Yu Ma, Yong-Tian Lin, Yan-Ping Chen, Hui-Juan Jiang, Lin-Rong Wu,  Chuan-Ben Chen

DOI: 10.4149/neo_2021_210203N168